Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$593M |
| 2 |
Abbott
ABT
|
+$259M |
| 3 |
AutoZone
AZO
|
+$204M |
| 4 |
AABA
Altaba Inc
AABA
|
+$186M |
| 5 |
D.R. Horton
DHI
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$215M |
| 2 |
Public Service Enterprise Group
PEG
|
+$211M |
| 3 |
Applied Materials
AMAT
|
+$203M |
| 4 |
Intuitive Surgical
ISRG
|
+$194M |
| 5 |
ConocoPhillips
COP
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.49% |
| 2 | Technology | 12.13% |
| 3 | Healthcare | 11.89% |
| 4 | Consumer Discretionary | 11.58% |
| 5 | Industrials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
PUT
Hershey
HSY
$36.4B
| $2.27M | ﹤0.01% |
+20,000
| New | +$2.2M |
|
2202
Neogen
NEOG
$2.56B
| $2.26M | ﹤0.01% |
+73,437
| New | +$2.23M |
|
2203
Frontline
FRO
$9.74B
| $2.26M | ﹤0.01% |
+492,986
| New | +$2.76M |
|
2204
Abeona Therapeutics
ABEO
$345M
| $2.26M | ﹤0.01% |
5,703
-3,798
| -40% | -$1.57M |
|
2205
iShares 7-10 Year Treasury Bond ETF
IEF
$43B
| $2.26M | ﹤0.01% |
+21,385
| New | +$2.27M |
|
2206
GameStop
GME
$8.19B
| $2.25M | ﹤0.01% |
502,488
+410,824
| +448% | +$1.92M |
|
2207
eHealth
EHTH
$36.5M
| $2.25M | ﹤0.01% |
129,480
+5,069
| +4% | +$113K |
|
|
GOL
2208
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $2.25M | ﹤0.01% |
256,351
-322,997
| -56% | -$2.84M |
|
2209
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
| $2.24M | ﹤0.01% |
26,691
-2,557
| -9% | -$216K |
|
|
KDNY
2210
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $2.24M | ﹤0.01% |
59,688
+2,198
| +4% | +$96K |
|
2211
CRISPR Therapeutics
CRSP
$5.74B
| $2.23M | ﹤0.01% |
95,130
+19,858
| +26% | +$377K |
|
2212
CALL
Vodafone
VOD
$36.7B
| $2.23M | ﹤0.01% |
+70,000
| New | +$2.1M |
|
2213
Enbridge
ENB
$109B
| $2.23M | ﹤0.01% |
+57,051
| New | +$2.19M |
|
|
OMED
2214
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $2.23M | ﹤0.01% |
543,335
+324,845
| +149% | +$1.41M |
|
2215
Byline Bancorp
BY
$1.73B
| $2.22M | ﹤0.01% |
96,829
-128,521
| -57% | -$2.67M |
|
2216
CALL
Align Technology
ALGN
$11.3B
| $2.22M | ﹤0.01% |
10,000
| – | – |
|
2217
Preformed Line Products
PLPC
$2.06B
| $2.22M | ﹤0.01% |
+31,232
| New | +$2.32M |
|
2218
Saia
SAIA
$9.39B
| $2.21M | ﹤0.01% |
31,258
+17,197
| +122% | +$1.1M |
|
2219
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.3B
| $2.21M | ﹤0.01% |
74,633
+37,610
| +102% | +$1.11M |
|
2220
Curis
CRIS
$3.64M
| $2.2M | ﹤0.01% |
1,575
+1,466
| +1,345% | +$3.45M |
|
|
USAK
2221
DELISTED
USA Truck Inc
USAK
| $2.2M | ﹤0.01% |
121,567
-6,646
| -5% | -$108K |
|
|
BV
2222
DELISTED
Bazaarvoice, Inc.
BV
| $2.2M | ﹤0.01% |
404,037
-915,047
| -69% | -$4.62M |
|
2223
Northern Trust
NTRS
$34.1B
| $2.2M | ﹤0.01% |
22,009
-1,569,032
| -99% | -$149M |
|
2224
Avista
AVA
$3.16B
| $2.2M | ﹤0.01% |
42,656
+21,860
| +105% | +$1.13M |
|
|
CHUBA
2225
DELISTED
CommerceHub, Inc. Series A Common Stock
CHUBA
| $2.19M | ﹤0.01% |
99,805
+47,054
| +89% | +$1.05M |
|
Similar funds
Israel Englander's Q4 2017 Portfolio in Review
As of Q4 2017, Israel Englander held 4,357 positions worth $72.5B, up 10% from $65.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander deployed $4.49B of net new capital in Q4 2017, opening 897 new positions and adding to 1,473 existing holdings. Its largest new stake was Viatris: 2,905,317 shares worth $123M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Honeywell, an estimated $215M trimmed.
- Israel Englander's largest Q4 2017 buy was Viatris: 2,905,317 shares worth $123M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $593M increase.
- Israel Englander's biggest Q4 2017 reduction was Honeywell, cutting an estimated $215M.
- Israel Englander fully exited Paychex in Q4 2017, selling an estimated $66.4M.
- Israel Englander's ten largest holdings make up 6.7% of its $72.5B portfolio in Q4 2017.
- Israel Englander opened 897 new positions and closed 601 in Q4 2017.
- Israel Englander's portfolio value rose 10% quarter-over-quarter to $72.5B.
Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.